Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (3): 508-511    DOI: 10.12892/ejgo4559.2019
Case Report Previous articles |
Sister Mary Joseph’s nodules as the presenting symptom of primary peritoneal carcinoma: a case report
T. Kihara1, *(), T. Kenzaka2, C. Suzuki1, Y. Nakashima1, S. Mochizuki1, M. Maruo1
1Department of Obstetrics and Gynecology, Hyogo Prefectural Kaibara Hospital, Tanba, Japan
2Division of Community Medicine and Career Development, Kobe University Graduate School of Medicine, Kobe, Japan
Download:  PDF(1648KB)  ( 201 ) Full text   ( 5 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Sister Mary Joseph’s nodule as the presenting symptom of primary peritoneal cancer is quite a rare finding. The authors report here an 82-year-old patient with Sister Mary Joseph’s nodule. She was diagnosed with primary peritoneal cancer and treated with surgical excision. Histological examination showed a papillary as well as a tubular pattern in the tumor. Adjuvant chemotherapy was administered but was discontinued because of the occurrence of pancytopenia. Although she could not avail of combination therapy, no recurrence has been observed at until now.

Key words:  Sister Mary Joseph’s nodule;      Peritoneal cancer      Surgical excision      Adjuvant chemotherapy     
Published:  10 June 2019     
*Corresponding Author(s):  T. KIHARA     E-mail:  tomosuke_usababy@yahoo.com

Cite this article: 

T. Kihara, T. Kenzaka, C. Suzuki, Y. Nakashima, S. Mochizuki, M. Maruo. Sister Mary Joseph’s nodules as the presenting symptom of primary peritoneal carcinoma: a case report. European Journal of Gynaecological Oncology, 2019, 40(3): 508-511.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4559.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I3/508

[1] Joseph J. Noh, Sir-Yeon Hong, Byeong-gie Kim. Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 495-499.
[2] H. Ishibashi, M. Miyamoto, T. Aoyama, H. Soyama, H. Matsuura, H. Iwahashi, M. Takano, K. Furuya. The effect of six scheduled cycles of neoadjuvant chemotherapy on prognosis in advanced ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 386-390.
[3] A. Lewandowska-Graduszewska, J. Markowska. Dermatomyositis in the course of primary peritoneal cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1055-1056.
[4] S. Dierckxsens, B. Geerinckx, M.T. Huizing, W.A.A. Tjalma. A review regarding the feasibility and accuracy of a sentinel lymph node biopsy after neo-adjuvant chemotherapy for breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 714-721.
[5] S. Cierniak, R. Koktysz, M. Jesiotr, A. Gąsowska-Bodnar, L. Bodnar. Expression of the PI3K/AKT/mTOR pathway as a prognostic factor in patients with advanced high grade serous ovarian carcinoma treated with neoadjuvant chemotherapy[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 744-751.
[6] S. Furukawa, K. Hasegawa, Y. Nozawa, Y. Endo, M. Takata, F. Yoshida-Saito, S. Nakamura, R. Yamauchi. A rare case of primary ovarian leiomyosarcoma[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 870-874.
[7] Lili Qian, Zhen Shen, Xuefen Zhang, Dabao Wu, Ying Zhou. Fertility-sparing management for bulky cervical cancer with systemic chemotherapy and conization: a case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 684-687.
[8] W.Y. Chay, A. Kumar, P.J. Hoskins, A.V. Tinker. Single-agent bevacizumab for the management of refractory malignant effusions in heavily pretreated patients with recurrent high-grade serous cancers of the ovary, fallopian tube or peritoneum: results from a single institution[J]. European Journal of Gynaecological Oncology, 2018, 39(6): 877-880.
[9] K. Yao, C. Bian, L. Li, Y. Wu, X. Zhao. The clinical response of advanced epithelial ovarian cancer patients to neoadjuvant chemotherapy in China[J]. European Journal of Gynaecological Oncology, 2018, 39(3): 377-380.
[10] C. Brooks, J. Sandhu, Y. Solberg, P. Athanasias. Primary peritoneal cancer in pregnancy: case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2018, 39(3): 479-482.
[11] J.A. Tidy, B.H. Brown, R.E. Lyon, T.J. Healey, J.E. Palmer. Are colposcopy and electrical impedance spectroscopy complementary when used to detect high-grade cervical neoplasia?[J]. European Journal of Gynaecological Oncology, 2018, 39(1): 70-75.
[12] W. Kudaka, T. Nakasone, Y. Arakaki, T. Nakamoto, A. Wakayama, Y. Kinjyo, Y. Taira, Y. Nagai, I. Kaneshima, K. Nishihira, Y. Aoki. Adjuvant docetaxel and carboplatin chemotherapy for patients with high-intermediate and high-risk endometrial cancer[J]. European Journal of Gynaecological Oncology, 2017, 38(6): 917-920.
[13] J.Y. Kwack, H.J. Roh, S.G. You, H.J. Cho, S.H. Lee, Y.S. Kwon. Chemotherapy-induced hemolytic uremic syndrome in locally advanced cervical cancer treated with combination chemotherapy after laparoscopic radical hysterectomy: a case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2017, 38(6): 956-959.
[14] H.J. Qian, T.G. Yu, G.F. Zhang, Y. Yu, D.Y. Geng, E. Harris, Y.M. Feng. Value of diffusion-weighted MRI in assessment of surgical margin of cervical cancer after loop electrosurgical excision procedure[J]. European Journal of Gynaecological Oncology, 2017, 38(4): 555-559.
[15] E.L. Liu, R.R. Mi, D.H. Wang, L.Q. Wang, Y.M. Zhang, W.M. Chen. Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites[J]. European Journal of Gynaecological Oncology, 2017, 38(2): 209-213.
No Suggested Reading articles found!